Your Vitamin D Supplements Just Failed a 69-Trial Test

The largest review ever done of calcium and vitamin D supplements has arrived with an awkward message for anyone who swallows one with breakfast: for most healthy older adults, that tablet is doing very little for their bones. The work was published in The BMJ and pooled 69 randomised controlled trials covering 1,53,902 adults.

The headline number is small enough to be sobering. Calcium taken alone made no meaningful difference. Vitamin D taken alone made no difference at all, and the researchers graded that finding as high certainty. Only the two taken together moved the needle — and even then, the effect worked out to roughly one fracture avoided for every 100 people who took the pills for two to three years.

That matters here more than in most countries. India's dietary supplements market touched about ₹20,146 crore in 2025, and vitamins and minerals make up roughly 38% of it. Calcium-with-D is one of the most casually prescribed combinations in Indian clinics, often handed over without a blood test, often continued for years. This review does not say those pills are harmful. It says most people are buying a much smaller benefit than they think.

What 69 Trials Put to the Test

The team, led by Olivier Massé, a pharmacist at Sacred Heart Hospital of Montreal in Canada, split the evidence into three clean buckets. Calcium alone drew on 11 trials and 9,067 people. Vitamin D alone drew on 36 trials and 92,045 people. The combination drew on 15 trials and 51,126 people. Average follow-up across the groups ran between two and about three years.

For the combined pills, the numbers did reach statistical significance: an 9% lower relative risk of any fracture, 16% lower for hip fractures, and 13% lower for non-hip fractures. Falls barely shifted. Those look like respectable figures until you convert them from relative risk into what actually happens to a hundred real people.

Why a Real Benefit Can Still Be Too Small

Here is the part that separates this review from the usual supplement headlines. Before running the analysis, the researchers wrote down what would count as worth it: at least a 0.7 percentage-point drop in hip fractures, 2 points for fractures generally, 3 points for falls. Setting that bar in advance stops anyone from declaring victory after the fact. The supplements cleared the statistics test and missed the bar.

These findings do not support routine supplementation with calcium, vitamin D or combined supplementation to prevent fractures or falls.

The authors went further than most reviewers do, calling on clinicians and drug regulators to revisit their blanket recommendations. That is a direct challenge to decades of advice that treated a daily calcium-and-D tablet as harmless common sense for anyone past sixty.

Who Should Not Stop Their Vitamin D Supplements

This is where the study's own fine print does real work, and where a lot of coverage will skip ahead. The trials mostly recruited general-population older adults. Several groups at genuine risk were barely represented or excluded outright, so the finding simply does not speak for them.

People Already Diagnosed With Osteoporosis

The review's authors say plainly that their results may not apply to anyone with a diagnosed bone disorder or anyone already on osteoporosis medication. Drugs like bisphosphonates are typically prescribed alongside calcium and vitamin D because the bone-building process needs the raw material. Stopping the supplement while continuing the drug is not a neutral decision.

Anyone Whose Blood Test Shows a Real Deficiency

Correcting a measured deficiency is a different medical problem from topping up someone who is already fine. Indian studies have reported vitamin D deficiency rates anywhere from 40% to 99% depending on the population studied, and one survey of apparently healthy South Indian men over 50 found 53% below the 20 ng/ml mark.

Older Adults Who Have Already Broken a Bone

Evidence remains thin for people with a previous fracture and for those living in care homes — exactly the groups where a hip fracture is most likely and most dangerous. Absence of proof here is not proof of absence, and the authors say so.

Why India's Bone Numbers Don't Map Neatly

Trials run largely in Europe, North America and Australia recruit people who mostly start out replete. Indian patients often don't. Research published in Osteoporosis International found that among Indian hip-fracture patients, 77% had low vitamin D, 69% had secondary hyperparathyroidism and 50% had biochemical osteomalacia — all far above matched controls.

The stakes are heavy. Working from roughly 2.7 crore Indian men above 65 and a reported hip-fracture rate of 105 per 1,00,000 in men over 50, researchers have estimated about 25,000 hip fractures a year in elderly Indian men alone — and a quarter to a third of them die within one to two years. Globally, about one in three adults over 65 falls each year.

What Works Better Than a Tablet

The review's recommendation is unglamorous and free: balance and resistance exercise. The authors also point to combined programmes that pair exercise with a walk-through of home hazards and personalised advice. Loose rugs, unlit stairwells, wet bathroom floors and slippery chappals cause more Indian hip fractures than any nutrient gap ever will.

Don't throw out the strip on the strength of a headline. If you're on calcium and vitamin D because a scan or blood report said so, keep taking it and raise the study at your next visit. If nobody ever tested you and the pills just accumulated over the years, that's the conversation worth having — and ask for a 25-hydroxy vitamin D test and a bone-density scan before anything gets stopped.